doi: 10.1016/j.neuropharm.2018.02.012 113
Another GLP agonist, lixisenatide (which is not approved for obesity), improved motor function in early Parkinsons disease (Meissner WG et al, N Eng J Med 2024;390:11761185)
Hence, prolonged IGF-1 or IGF-1 gene therapy could disrupt the nuclear p53progerin interaction to repress oxidative SIPS via activating the PI3K/AKT1 pathway and inhibiting p53 nuclear translocation
It absorbs well, supports your immune system, keeps your energy up, and helps protect your cells from daily damage
48 Overall, it is suggested that glutathione might promote pheomelanin synthesis, inhibit intracellular melanogenic enzymes, and exhibit antioxidant and anti-aging effects